Halozyme Therapeutics
HALO
#2398
Rank
โ‚ฌ5.88 B
Marketcap
46,28ย โ‚ฌ
Share price
1.19%
Change (1 day)
29.95%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): โ‚ฌ0.43 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.94 Billion. In 2023 the company made an earning of โ‚ฌ0.33 Billion, an increase over its 2022 earnings that were of โ‚ฌ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.43 B32.09%
2023 โ‚ฌ0.33 B39.94%
2022 โ‚ฌ0.23 B0.16%
2021 โ‚ฌ0.23 B92.2%
2020 โ‚ฌ0.12 B-278.96%
2019 -โ‚ฌ68.8 Million-9.45%
2018 -โ‚ฌ75.98 Million-229.51%
2017 โ‚ฌ58.66 M-160.48%
2016 -โ‚ฌ97 Million216.03%
2015 -โ‚ฌ30.7 Million-52.86%
2014 -โ‚ฌ65.11 Million-18.09%
2013 -โ‚ฌ79.49 Million55.88%
2012 -โ‚ฌ51 Million169.94%
2011 -โ‚ฌ18.9 Million-63.44%
2010 -โ‚ฌ51.67 Million-7.19%
2009 -โ‚ฌ55.67 Million15.91%
2008 -โ‚ฌ48.03 Million83.89%
2007 -โ‚ฌ26.12 Million78.1%
2006 -โ‚ฌ14.67 Million16%
2005 -โ‚ฌ12.65 Million45.24%
2004 -โ‚ฌ8.71 Million682.42%
2003 -โ‚ฌ1.12 Million1659.12%
2002 -โ‚ฌ0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ23.83 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.66 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.15 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.61 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.05 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ17.51 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA